Michelle Liu

发表

Vasomotor symptoms in early breast cancer—a “real world” exploration of the patient experience

G. Pond, K. Emam, M. Clemons, 2022, Supportive Care in Cancer.

Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers

M. Clemons, L. Vandermeer, Mashari Alzahrani, 2022, Supportive Care in Cancer.

Using machine learning to predict individual patient toxicities from cancer treatments

G. Pond, K. Emam, M. Clemons, 2022, Supportive Care in Cancer.

Using machine learning to predict individual patient toxicities from cancer treatments

G. Pond, K. Emam, M. Clemons, 2022, Supportive Care in Cancer.

The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer

B. Hutton, M. Clemons, A. Arnaout, 2021, Cancer Treatment Reviews.

Prospective randomised controlled trial using the REthinking Clinical Trials (REaCT) platform and National Surgical Quality Improvement Program (NSQIP) to compare no preparation versus preoperative oral antibiotics alone for surgical site infection rates in elective colon surgery: a protocol

M. Clemons, K. Thavorn, D. Fergusson, 2020, BMJ Open.

The Rethinking Clinical Trials (REaCT) Program. A Canadian-Led Pragmatic Trials Program: Strategies for Integrating Knowledge Users into Trial Design

B. Hutton, M. Clemons, L. Vandermeer, 2021, Current oncology.

Can routinely collected administrative data effectively be used to evaluate and validate endpoints used in breast cancer clinical trials? Protocol for a scoping review of the literature

M. Clemons, B. Hutton, C. Lunny, 2023, Systematic Reviews.

Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program

B. Hutton, M. Clemons, L. Vandermeer, 2022, Current oncology.